FDA Drug Compounding Enforcement Continues With Teregen Labs Citation
This article was originally published in The Pink Sheet Daily
Executive Summary
The Gentere subsidiary distributes compounded drug products for those commercially available and without valid prescriptions, an FDA warning letter states. The agency also cites the firm for cGMP violations.